Hirahata Gene Therapy Clinic

An independent research clinic specializing in
gene therapy for the prevention of cancer and infectious disease


HIC Clinic is committed to the prevention of some of the most serious diseases commonly found in society. Our clinic houses its own laboratory which supports the provision of state-of-the-art medical care, including cancer therapies and prophylactic measures to prevent infectious disease, based on many years of research undertaken by Dr. Tetsuyuki Hirahata—director of the clinic and a leading expert in the field of genetic research.

Tetsuyuki Hirahata, M.D., Ph.D.

Director of HIC Clinic

Director of HIC Clinic

Dr. Hirahata graduated from Toho University School of Medicine in 1974 and joined its Faculty of Internal Medicine I: Hematology in 1975. He continued his work as a research fellow in the Faculty of Internal Medicine (Hematology/Oncology) at East Carolina University School of Medicine.

Upon returning to Japan, he established Hirahata Clinic and also founded UDX Hirahata Clinic and its affiliated research institute in Akihabara, Tokyo, in 2008. Both medical facilities were created to provide specialized healthcare services in the fields of genetic testing and treatment, and Dr. Hirahata continues to advance these same lines of research at HIC Clinic and its associated research laboratory.

  • Former President of Soyukai Medical Corporation
  • Former Director of the Institute for Genetic Diagnosis and Treatment
  • Board-Certified Physician, American Academy of Anti-Aging Medicine (A4M)
  • Professional Affiliations: Japanese Society of Internal Medicine, Japan Pancreas Society, Japanese Society for Gene Diagnosis and Therapy, Japan Society of Human Genetics, and American Society of Human Genetics.